http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103570564-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
filingDate 2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103570564-B
titleOfInvention A kind of Propafenone drug enantiomer method for splitting
abstract The invention provides a kind of Propafenone drug enantiomer method for splitting.The method with Propafenone hydrochloride for split object, first Propafenone hydrochloride is converted into Propafenone episome, with L-TARTARIC ACID ester class and boric acid as resolution reagent, L-TARTARIC ACID ester class is added in organic phase, boric acid adds in aqueous phase, adopts high-speed countercurrent chromatography to obtain left-handed Propafenone and dextrorotation Propafenone.Compared with prior art, beneficial effect of the present invention is mainly reflected in: adopt present method resolving chiral medicine Propafenone can reach higher resolution, and the method is applicable to the preparative counter current chromatograph of various model, can be separated the monomer obtaining left-handed Propafenone and dextrorotation Propafenone.
priorityDate 2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454095338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453148806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432173875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141311437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36708

Total number of triples: 52.